Director/PDMR Shareholding

Summary by AI BETAClose X

Nicola Blackwood, a non-executive director of RTW Biotech Opportunities Ltd, has disclosed the purchase of an aggregate of 23,373 ordinary shares during the fourth quarter of 2025. These transactions, which occurred on October 6, 2025, and December 23, 2025, on the London Stock Exchange, were initially omitted from public disclosure due to an oversight but have since been rectified. The shares were acquired at an average price of $1.7439, with individual purchase prices ranging from $1.5585 to $2.18844.

Disclaimer*

UK 100

Latest directors dealings